The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So, if you look at epigenetic code for two different hpatocytes, liver cells, one from a 20year-old, one from a 50y old. Uh, and then and I tell you which one's 20, which one's 50, and then I show you a bunch of others. You can always tell which one's the older one, which one's the younger one.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.